{"id":"W2954811145","doi":"10.1158/1538-7445.am2019-ct183","title":"Abstract CT183: Phase (Ph) I/II study of MBG453± spartalizumab (PDR001) in patients (pts) with advanced malignancies","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Cancer; Pancreatic cancer; Gastroenterology; Toxicity; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003878218,0.0001414968,0.0004158492,0.0004762343,0.00007677208,0.00001482873,0.0001343661,0.00005456133,0.001942768],"category_scores_gemma":[0.00006699797,0.000108546,0.00005818887,0.0009298873,0.0001137089,0.0001456571,0.0000766313,0.0003706893,0.0000714991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002396949,"about_ca_system_score_gemma":0.0002479755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007637464,"about_ca_topic_score_gemma":0.0007399612,"domain_scores_codex":[0.9976594,0.00007693793,0.0003533761,0.0003858739,0.001090259,0.0004341187],"domain_scores_gemma":[0.9987012,0.00005238126,0.00009297724,0.0004544172,0.0005420646,0.0001569456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01041787,0.02009272,0.7467621,0.0008808488,0.0003945204,0.0002593101,0.005498912,0.0004318927,0.1902686,0.0000785321,0.00242081,0.02249382],"study_design_scores_gemma":[0.0911269,0.02448751,0.774147,0.005163118,0.0001035906,0.000004453662,0.01210664,0.0001458989,0.08885673,0.00003976989,0.003220881,0.0005975047],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966308,0.00009733132,8.006922e-7,0.0001907633,0.00002051156,0.001077016,0.00003398215,0.00001810483,0.001930701],"genre_scores_gemma":[0.9979886,0.00003591256,0.0000154503,0.00005094236,0.00003479246,0.0001456664,0.00003575486,0.00002445896,0.001668371],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1014119,"threshold_uncertainty_score":0.9989696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0518266288122539,"score_gpt":0.4116926234289976,"score_spread":0.3598659946167437,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}